WO2022106123A1 - Two component sunscreen - Google Patents
Two component sunscreen Download PDFInfo
- Publication number
- WO2022106123A1 WO2022106123A1 PCT/EP2021/078091 EP2021078091W WO2022106123A1 WO 2022106123 A1 WO2022106123 A1 WO 2022106123A1 EP 2021078091 W EP2021078091 W EP 2021078091W WO 2022106123 A1 WO2022106123 A1 WO 2022106123A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- weight
- composition
- polymer
- preferred
- proceeding
- Prior art date
Links
- 230000000475 sunscreen effect Effects 0.000 title description 16
- 239000000516 sunscreening agent Substances 0.000 title description 16
- 239000002537 cosmetic Substances 0.000 claims abstract description 20
- 239000000203 mixture Substances 0.000 claims description 130
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 37
- 229920000642 polymer Polymers 0.000 claims description 29
- 239000004904 UV filter Substances 0.000 claims description 23
- 125000004432 carbon atom Chemical group C* 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 239000000178 monomer Substances 0.000 claims description 17
- -1 3-(4- (2,2-bisethoxycarbonylvinyl)phenoxy)propenyl Chemical group 0.000 claims description 15
- 150000003839 salts Chemical class 0.000 claims description 15
- 150000003973 alkyl amines Chemical class 0.000 claims description 14
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 12
- 150000001412 amines Chemical class 0.000 claims description 11
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 claims description 10
- 230000004224 protection Effects 0.000 claims description 10
- 239000000243 solution Substances 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 9
- 230000005855 radiation Effects 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 7
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 claims description 5
- 239000011248 coating agent Substances 0.000 claims description 5
- 238000000576 coating method Methods 0.000 claims description 5
- 239000012038 nucleophile Substances 0.000 claims description 5
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 claims description 5
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 4
- 239000007983 Tris buffer Substances 0.000 claims description 4
- 150000001298 alcohols Chemical class 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 239000007795 chemical reaction product Substances 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 claims description 3
- OIQXFRANQVWXJF-QBFSEMIESA-N (2z)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=CC=C1 OIQXFRANQVWXJF-QBFSEMIESA-N 0.000 claims description 3
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 claims description 3
- CENPSTJGQOQKKW-UHFFFAOYSA-N 2,4,6-tris(4-phenylphenyl)-1,3,5-triazine Chemical compound C1=CC=CC=C1C1=CC=C(C=2N=C(N=C(N=2)C=2C=CC(=CC=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)C=2C=CC=CC=2)C=C1 CENPSTJGQOQKKW-UHFFFAOYSA-N 0.000 claims description 3
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 claims description 3
- KKJKXQYVUVWWJP-UHFFFAOYSA-N 4-[(4,7,7-trimethyl-3-oxo-2-bicyclo[2.2.1]heptanylidene)methyl]benzenesulfonic acid Chemical class CC1(C)C2CCC1(C)C(=O)C2=CC1=CC=C(S(O)(=O)=O)C=C1 KKJKXQYVUVWWJP-UHFFFAOYSA-N 0.000 claims description 3
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 claims description 3
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 3
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 claims description 3
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 claims description 3
- 229920001577 copolymer Polymers 0.000 claims description 3
- HUVYTMDMDZRHBN-UHFFFAOYSA-N drometrizole trisiloxane Chemical compound C[Si](C)(C)O[Si](C)(O[Si](C)(C)C)CC(C)CC1=CC(C)=CC(N2N=C3C=CC=CC3=N2)=C1O HUVYTMDMDZRHBN-UHFFFAOYSA-N 0.000 claims description 3
- 229960004881 homosalate Drugs 0.000 claims description 3
- 125000001841 imino group Chemical group [H]N=* 0.000 claims description 3
- MJVGBKJNTFCUJM-UHFFFAOYSA-N mexenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(C)C=C1 MJVGBKJNTFCUJM-UHFFFAOYSA-N 0.000 claims description 3
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 claims description 3
- LXTZRIBXKVRLOA-UHFFFAOYSA-N padimate a Chemical compound CCCCCOC(=O)C1=CC=C(N(C)C)C=C1 LXTZRIBXKVRLOA-UHFFFAOYSA-N 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 3
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims description 2
- 150000007513 acids Chemical class 0.000 claims description 2
- DTVQVQGCVNNOSX-UHFFFAOYSA-N bis(2-ethylhexyl) 2-[(4-methoxyphenyl)methylidene]propanedioate Chemical compound CCCCC(CC)COC(=O)C(C(=O)OCC(CC)CCCC)=CC1=CC=C(OC)C=C1 DTVQVQGCVNNOSX-UHFFFAOYSA-N 0.000 claims description 2
- HEAHZSUCFKFERC-UHFFFAOYSA-N ecamsule Chemical compound CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)C2=CC(C=C1)=CC=C1C=C1C(=O)C2(CS(O)(=O)=O)CCC1C2(C)C HEAHZSUCFKFERC-UHFFFAOYSA-N 0.000 claims description 2
- DZVCFNFOPIZQKX-LTHRDKTGSA-M merocyanine Chemical compound [Na+].O=C1N(CCCC)C(=O)N(CCCC)C(=O)C1=C\C=C\C=C/1N(CCCS([O-])(=O)=O)C2=CC=CC=C2O\1 DZVCFNFOPIZQKX-LTHRDKTGSA-M 0.000 claims description 2
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical class OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 claims description 2
- 150000003141 primary amines Chemical class 0.000 claims description 2
- 229920006395 saturated elastomer Polymers 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical class OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 claims description 2
- 150000003573 thiols Chemical class 0.000 claims description 2
- 125000003700 epoxy group Chemical group 0.000 claims 1
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
- 239000000839 emulsion Substances 0.000 description 12
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 8
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 7
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 7
- 150000002118 epoxides Chemical group 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 230000006750 UV protection Effects 0.000 description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 6
- 229960005323 phenoxyethanol Drugs 0.000 description 6
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 5
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 229940100524 ethylhexylglycerin Drugs 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 4
- HAZWONBCJXKAMF-UHFFFAOYSA-N 2-[1-[1,3-bis[2-(oxiran-2-ylmethoxy)propoxy]propan-2-yloxy]propan-2-yloxymethyl]oxirane Chemical compound C1OC1COC(C)COCC(OCC(C)OCC1OC1)COCC(C)OCC1CO1 HAZWONBCJXKAMF-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 4
- 239000006254 rheological additive Substances 0.000 description 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 4
- 239000011787 zinc oxide Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000004408 titanium dioxide Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- YVLPJIGOMTXXLP-UHFFFAOYSA-N 15-cis-phytoene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CC=CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C YVLPJIGOMTXXLP-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- 229940081733 cetearyl alcohol Drugs 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 239000008406 cosmetic ingredient Substances 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- 229960003720 enoxolone Drugs 0.000 description 2
- 229940068171 ethyl hexyl salicylate Drugs 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- KAZSKMJFUPEHHW-UHFFFAOYSA-N (2E)-3-[5-(1,1-dimethyl-2-propenyl)-4-hydroxy-2-methoxyphenyl]-1-(4-hdyroxyphenyl)-2-propen-1-one Natural products COC1=CC(O)=C(C(C)(C)C=C)C=C1C=CC(=O)C1=CC=C(O)C=C1 KAZSKMJFUPEHHW-UHFFFAOYSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- SBLKVIQSIHEQOF-OWOJBTEDSA-N (e)-octadec-9-enedioic acid Chemical compound OC(=O)CCCCCCC\C=C\CCCCCCCC(O)=O SBLKVIQSIHEQOF-OWOJBTEDSA-N 0.000 description 1
- YVLPJIGOMTXXLP-UUKUAVTLSA-N 15,15'-cis-Phytoene Natural products C(=C\C=C/C=C(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C YVLPJIGOMTXXLP-UUKUAVTLSA-N 0.000 description 1
- YVLPJIGOMTXXLP-BAHRDPFUSA-N 15Z-phytoene Natural products CC(=CCCC(=CCCC(=CCCC(=CC=C/C=C(C)/CCC=C(/C)CCC=C(/C)CCC=C(C)C)C)C)C)C YVLPJIGOMTXXLP-BAHRDPFUSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- PFPQMWRASYNLMZ-LGIMBNBCSA-N 2-(3,4-dihydroxyphenyl)-3-[(2s,3r,4r,5s,6r)-3,4-dihydroxy-5-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-5,7-dihydroxychromen-4-one Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 PFPQMWRASYNLMZ-LGIMBNBCSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- NPSJHQMIVNJLNN-UHFFFAOYSA-N 2-ethylhexyl 4-nitrobenzoate Chemical compound CCCCC(CC)COC(=O)C1=CC=C([N+]([O-])=O)C=C1 NPSJHQMIVNJLNN-UHFFFAOYSA-N 0.000 description 1
- 239000004808 2-ethylhexylester Substances 0.000 description 1
- CLAHOZSYMRNIPY-UHFFFAOYSA-N 2-hydroxyethylurea Chemical compound NC(=O)NCCO CLAHOZSYMRNIPY-UHFFFAOYSA-N 0.000 description 1
- JRJBVWJSTHECJK-PKNBQFBNSA-N 3-Methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one Chemical compound CC(=O)C(\C)=C\C1C(C)=CCCC1(C)C JRJBVWJSTHECJK-PKNBQFBNSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 1
- 108010087806 Carnosine Proteins 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 235000000638 D-biotin Nutrition 0.000 description 1
- 239000011665 D-biotin Substances 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- IUCVKTHEUWACFB-UHFFFAOYSA-N Licochalcone A Natural products COC1=CC=C(C(C)(C)C=C)C=C1C=CC(=O)C1=CC=C(O)C=C1 IUCVKTHEUWACFB-UHFFFAOYSA-N 0.000 description 1
- KAZSKMJFUPEHHW-DHZHZOJOSA-N Licochalcone A Chemical compound COC1=CC(O)=C(C(C)(C)C=C)C=C1\C=C\C(=O)C1=CC=C(O)C=C1 KAZSKMJFUPEHHW-DHZHZOJOSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000009692 acute damage Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001335 aliphatic alkanes Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 1
- 229940044199 carnosine Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229960005191 ferric oxide Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229930013032 isoflavonoid Natural products 0.000 description 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 1
- 235000012891 isoflavonoids Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- YBGZDTIWKVFICR-UHFFFAOYSA-N octinoxate Chemical compound CCCCC(CC)COC(=O)C=CC1=CC=C(OC)C=C1 YBGZDTIWKVFICR-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 231100000760 phototoxic Toxicity 0.000 description 1
- 235000011765 phytoene Nutrition 0.000 description 1
- 229920002959 polymer blend Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229940033134 talc Drugs 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 229960005196 titanium dioxide Drugs 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 239000008307 w/o/w-emulsion Substances 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/54—Polymers characterized by specific structures/properties
- A61K2800/544—Dendrimers, Hyperbranched polymers
Definitions
- the present invention belongs to the cosmetic field and relates to a two component sunscreen composition allowing for an effective protection of the human skin from UV radiation. Furthermore, the invention is directed to a method of protecting the human skin from UV radiation.
- a beautiful and attractive appearance is a desire for many people.
- One typical sign of such an appearance is a healthy and smooth looking skin. Therefore, in order to take care on the skin, it is for many people a daily routine to apply cosmetic products such as body lotions and sunscreen compositions.
- compositions containing UV-filters are commonly used to protect the skin from the ultraviolet (UV) radiation of the sunlight.
- UV ultraviolet
- longterm damage such as an increased risk of skin cancer occurs in case of excessive irradiation with light from the UV-B range (wavelength: 280-320 nm).
- the excessive exposure of UV-B and UV-A radiation (wavelength: 320-400 nm) also leads to a weakening of the elastic and collagen fibers of the connective tissue. This leads to numerous photo-toxic and photo- allergic reactions and results in premature skin ageing.
- UV-A and UV-B filters are grouped in the most developed countries in the form of positive lists such as Annex VI of the Regulation (EC) No 1223/2009 of the European Parliament and of the Council.
- sunscreen may be removed with water e.g. by swimming in the sea.
- water resistance of the applied sunscreen may vary.
- water resistance of conventional sunscreen compositions is still limited. Accordingly, there is a general need to provide measures to increase the water resistance on the human skin of sunscreens.
- compositions comprising a coating solution prepared by mixing glyceryl propoxylate triglycidyl ether with octadecylamine in ethanol. However, the article does not disclose cosmetic compositions at all.
- the present invention is a method of protection of the human skin from UV radiation, in particular IIV-A and/or IIV-B radiation, involving the steps of a) applying a first cosmetic composition A comprising a polymer polymerized from a monomer mixture comprising
- R 1 stands independently for an alkylgroup having 1 to 4 carbon atoms or a hydrogen atom
- R 2 stands independently for a linear or branched, saturated or non-saturated hydrocarbon group containing 1 to 18 carbon atoms or a hydrogen atom, and u, v, w, x, y and z stand independently for an integer number in the range from 1 to 100; and
- a second aspect of the invention is the use of a polymer polymerized from a monomer mixture comprising
- a third aspect of the invention is a cosmetic composition A comprising at least one polymer polymerized from a monomer mixture comprising
- a forth aspect of the invention is a kit comprising the cosmetic composition A and a second cosmetic composition B, wherein the second composition comprises at least one UV filter.
- a fifth aspect of the invention is a polymer polymerized from a monomer mixture comprising
- the invention allows the UV protection factor to be achieved to be significantly increased. Further, a more even coverage of the UV filters is achieved upon application to a skin or a surface. Accordingly, the objectives of the present invention are solved.
- normal conditions refers to 20°C, 1013 hPa and a relative humidity of 50%.
- the terms ..according to the invention”, “preferred according to the invention” and so on are always directed to the use according to the invention, to the method according to the invention and to the cosmetic composition according to the invention.
- the term “free from” means that the proportion of the respective polymer is less than 0.05% by weight. This ensures that entrainments or impurities with these polymers are not included as “free from” according to the invention.
- skin refers solely to the human skin.
- Emulsifiers are understood to be all substances which are listed in the International Cosmetic Ingredient Dictionary and Handbook, Thirteenth Edition 2010, (ISBN 1-882621-47-6) under the name "emulsifying agent”.
- Surfactants are understood to be all substances which are listed in the International Cosmetic Ingredient Dictionary and Handbook, Thirteenth Edition 2010, (ISBN 1-882621-47-6) under the name "surfactant”.
- the amine reacts with the epoxide groups of the triglycidylether allowing a structured network to be created.
- the amine allows for nucleophilic substitution at the carbon atom with the OH group or the Nu group. It should be noted that every amine may react with up to two triglycidylether such that extensive crosslinking occurs, allowing not a clear chemical structure to be defined.
- the polymer is polymerized from a monomer mixture comprising
- the polymer is polymerized from a monomer mixture comprising
- the polymer is polymerized from a monomer mixture comprising
- the polymer is polymerized from a monomer mixture comprising
- R 1 is a hydrogen atom. It is further preferred if the sum of the integer values of x, y and z is less than 20, more preferred less than 10 and most preferred less than 6. It is most preferred if x, y and z are all equal to 1.
- R 1 is a hydrogen atom.
- R 2 stands for a methyl group and/or a hydrogen atom, whereby it is most preferred if R 2 stands for a methyl group.
- the sum of the integer values of u, v and w is less than 20, more preferred less than 10 and most preferred less than 6. It is most preferred if u, v and w are all equal to 1 .
- the amine is a primary amine. It is further preferred if the amine comprises a linear alkyl chain comprising 10 to 25 carbon atoms, more preferably 14 to 22 and most preferred 18 carbon atoms.
- the polymer of the invention is preferably formed by a) dissolving the triglycidylether accoding to the invention in ethanol, b) then adding the amine to the solution, and c) stirring the obtained mixture to obtain the product.
- the ratio by weight between the triglycidylether accoding to the invention and ethanol is in the range from 1:1 to 1 :100, more preferably from 1 :2 to 1:50, more preferably from 1 :5 to 1 :20, and most preferred from 1 :9 to 1 :11.
- the mixture is stirred at 50°C for at least 5 minutes. Most preferably for 12 to 20 minutes.
- ethanol may be removed from the reaction product.
- reaction product obtained in step c) is further reacted in a further step d) with another nucleophile in order to ensure that all epoxide groups are opened and no closed epoxide rings remain in the polymeric structure.
- Preferred nucleophiles may be selected from the group of water, alcohols, amines, hydrohalic acids, thiols and/or phosphorous acids. Most preferred nucleophils are water, hydrochloric acid, and alcohols.
- the polymers formed according to the invention are characterized in that they have an average molecular weight in the range from 1000 to 1000000 Dalton, more preferably in the range from 3000 to 100000 Dalton and most preferably 4000 to 10000 Dalton.
- the average molecular weight of the polymers according to the invention is determined by GPC analysis using a reference material, eg. Poly(styrene) standards.
- the cosmetic composition A which is according to the invention, comprises the polymer according to the invention in a total quantity ranging from 0.5 to 30% by weight, more preferably 1 to 20% by weight and most preferably from 5 to 18% by weight, calculated to the total weight of the composition A.
- Composition A is further preferably characterized in that in comprises ethanol. If ethanol is contained, the total quantity of ethanol is preferably in the range from 15 to 95% by weight, more preferably from 50 to 90% by weight and most preferably from 60 to 80% by weight, calculated to the total weight of the composition A. Moreover, it is further preferred if the composition A comprises water. If water is contained, the total quantity of water is preferably in the range from 5 to 95% by weight, more preferably from 15 to 80% by weight and most preferably from 20 to 70% by weight, calculated to the total weight of the composition A.
- the composition A comprises glycerol. If glycerol is contained, the total quantity of glycerol is preferably in the range from 1 to 30% by weight, more preferably from 2 to 20% by weight and most preferably from 2 to 10% by weight, calculated to the total weight of the composition A.
- composition A may further comprise additional ingredients commonly contained in cosmetic compositions.
- composition A comprises ethylhexylglycerin, hexandiol, and/or phenoxyethanol.
- ethylhexylglycerin is contained it is preferred if the total quantity of ethylhexylglycerin is in the range from 0.1 to 3% by weight, calculated to the total weight of composition A.
- hexandiol is contained it is preferred if the total quantity of hexandiol is in the range from 0.1 to 3% by weight, calculated to the total weight of composition A.
- phenoxyethanol is contained it is preferred if the total quantity of phenoxyethanol is in the range from 0.1 to 3% by weight, calculated to the total weight of composition A.
- composition A comprises propylene glycol, whereby it is further preferred if the total quantity of propylene glycol is in the range from 1 to 30% by weight, calculated to the total weight of the composition A.
- composition A may comprise panthenol, urea, cera microcristallina, cetyl palmitate, sodium hyaluronate, glycyrrhetinic acid, ascorbic acid, caffeine, menthol, titanium oxide, zinc oxide, iron oxide, talc, perfume and/or emulsifier.
- the composition A is characterized in that no UV-filter is contained.
- the composition A comprises at least one water- soluble UV filter.
- Embodiments of the present invention which are advantageous according to the invention are characterized in that the total amount of water-soluble UV filters in the preparation is from 0.1 to 18% by weight, based on the total weight of the composition A.
- sulfonic acid salts are used as water-soluble UV filters.
- Preferred examples are 1 , 4-di (2-oxo-10-sulfo-3-bomylidenemethyl) benzene and its salts; 4- (2-oxo-3-bornylidenemethyl) benzenesulfonic acid; 2-methyl-5- (2-oxo-3- bornylidenemethyl) sulfonic acid salts; Terephthalidendicamphersulfonsaure; Compounds 2- phenylbenzimidazole-5-sulfonic acid and I or salts thereof and I or phenylene-1,4-bis (2- benzimidazyl) -3,3'-5,5'-tetrasulfonic acid salts.
- the counterion of the salts is usually sodium, potassium or ammonium ions, the sodium salts being preferred according to the invention.
- the water-soluble UV filters are preferably selected from the group of the compounds 2-phenylbenzimidazole-5-sulfonic acid and I or salts thereof and I or phenylene-1 ,4-bis (2-benzimidazyl) -3,3'-5 , 5'-tetrasulfonsauresalze.
- the use of 2- phenylbenzimidazole-5-sulfonic acid and I or salts thereof is particularly preferred according to the invention.
- the preferred use concentration for 2-phenylbenzimidazole-5-sulfonic acid and I or salts thereof is from 0.1 to 12% by weight, based on the total weight of the composition A.
- composition A comprises at least one additional UV-filter, which may preferably be selected from the group consisting of 2,2'- methylene-bis- (6- (2H-benzotriazol-2-yl) -4- (1 , 1 , 3,3-tetramethylbutyl) phenol); 2- (2H- Benzotriazol-2-yl) -4-methyl-6- [2-methyl-3- [1 ,3,3,3-tetramethyl-1 - [(trimethylsilyl) oxy] disiloxanyl] propyl] phenol ; 3- (4-methylbenzylidene) camphor; 3-benzylidenecamphor; ethylhexyl salicylate; 2-ethylhexyl-2-cyano-3,3-diphenylacrylate; 4- (dimethylamino) benzoic acid (2-ethylhexyl) ester; 4- (dimethylamino) benzoic acid amyl ester; 4- Meth
- composition A contains at least one UV filter
- composition B a conventional cosmetic sunscreen, herein named as composition B
- composition B is an emulsion.
- Emulsions here in particular W/O, O/W or W/O/W emulsions, are often used as cosmetic or medical preparations.
- Emulsions are generally understood as meaning heterogeneous systems which comprise two liquids which are immiscible or only miscible with one another to a limited extent, which liquids are normally referred to as phases.
- one of the two liquids is dispersed in the other liquid in the form of very fine droplets.
- O/W emulsion oil in water emulsion
- the basic character of an O/W emulsion is determined by the water.
- W/O emulsion water-in-oil emulsion, e.g., butter
- the principle is reversed, the basic character here being determined by the oil.
- composition B is a single phase alcohol (ethanol) containing formulation.
- ethanol a single phase alcohol
- High quantities of ethanol are used in this kind of formulations in order to provide a clear solution of all ingredients.
- the amount is ethanol is chosen to be sufficient to form a stable and transparent single phase formulation.
- composition B is preferably characterized in that it is an O/W emulsion, a W/O emulsion or a single phase alcoholic solution.
- Composition B comprises at least one UV filter.
- composition B according to the invention is advantageously characterized in that the composition comprises one or more organic IIV-A filters selected from the group of the compounds 4- (tert-butyl) -4'-methoxydibenzoylmethane and 2- (4'-diethylamino-2 ' - hydroxybenzoyl) -benzoic acid hexyl ester.
- organic IIV-A filter compound 4- (tert-butyl) -4'- methoxydibenzoylmethane is used in composition B.
- the advantageous total use according to the invention for the organic IIV-A filter in particular 4- (tert-butyl) -4'-methoxydibenzoylmethane and/or 2- (4'-diethylamino-2'- hydroxybenzoyl) - benzoic acid hexyl ester, is/are from 1 to 5 weight -%, preferably 1.5 to 4.5% by weight, particularly preferably 2 to 4% by weight, based on the total weight of the composition B.
- Embodiments of the present invention which are advantageous according to the invention are characterized in that the composition B contains one or more organic UV filters selected from the group of the compounds 2-phenylbenzimidazole-5-sulphonic acid and/or salts thereof; phenylene-1,4-bis(2-benzimidazyl)-3,3'-5,5'-tetrasulphonic acid salts; 1,4-di(2-oxo- 10-sulpho-3-bornylidenemethyl)benzene and salts thereof; 4-(2-oxo-3- bornylidenemethyl)benzenesulphonic acid salts; 2-methyl-5-(2-oxo-3- bornylidenemethyl)sulphonic acid salts; 2,2'-methylenebis(6-(2H-benzotriazol-2-yl)-4- (1,1 , 3, 3-tetramethyl butyl) phenol); 2-(2H-benzotriazol-2-yl)-4-methyl-6-[2-methyl-3-[1 ,3,3,3
- the composition B contains 2-phenylbenzimidazole-5-sulfonic acid and I or salts thereof.
- the total quantity of those substances is preferably in the range from 0.5 to 5% by weight, more preferably 0.6 to 4.5% by weight and most preferably 0.8 to 4% by weight, based on the total weight of the composition B.
- composition B comprises 2-ethylhexyl-2-cyano-3,3- diphenylacrylate (octocrylene), whereby it is further preferred if the total quantity of this substance is in the range from 1 to 12% by weight, preferably 1.5 to 6% by weight, particularly preferably 2 to 3.5% by weight based on the total weight of composition B.
- octocrylene 2-ethylhexyl-2-cyano-3,3- diphenylacrylate
- composition B comprises Homosalate in a total quantity from 1 to 12% by weight, preferably 1.5 to 6% by weight, particularly preferably 2 to 3.5% by weight based on the total weight of composition B.
- composition B comprises Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine in a total quantity from 0.5 to 12% by weight, preferably 0.6 to 6% by weight, particularly preferably 0.7 to 2.5% by weight based on the total weight of composition B.
- composition B comprises Ethylhexyl Salicylate in a total quantity from 0.5 to 12% by weight, preferably 2 to 9% by weight, particularly preferably 3 to 7.5% by weight based on the total weight of composition B.
- composition B comprises Silica Dimethyl Silylate in a total quantity from 0.1 to 2% by weight, preferably 0.4 to 1.5% by weight, particularly preferably 0.6 to 1.3% by weight based on the total weight of composition B.
- the composition B of the present invention is preferably characterized in that at least one inorganic UV-filter is contained, especially zinc oxide and/or titanium dioxide. It is especially preferred, if the total quantity of zinc oxide and/or titanium dioxide in the composition B of the present invention is in the range from 0.1 to 5% by weight, calculated to the total weight of the composition B.
- composition B is an emulsion
- the total quantity of the oil phase in the composition B is in the range from 0.9 to 25% by weight, more preferably 1 to 20% by weight, more preferably 1.1 to 19% by weight and most preferably from 1.2 to 18% by weight, calculated to the total weight of the composition B.
- composition B is an emulsion
- the ratio of the total quantity of the emulsifier to the total quantity of the oil phase is in the range from 1:1 to 1 :7, more preferably 1:1.1 to 1 :4, more preferably 1 :1.2 to 1:3 and most preferably 1:1.4 to 1:2.8. It is noted that by definition emulsifier and surfactants are not calculated to the total quantity of the oil phase.
- the composition B contains phenoxyethanol.
- the total quantity of phenoxyethanol is preferably in the range from 0.1 % by weight to 2% by weight and more preferably from 0.4% by weight to 1% by weight, calculated to the total weight of the composition B.
- composition B of the present invention are therein characterized that they contain ethylhexylglycerin, whereby it is further preferred if the total quantity of ethylhexylglycerin is in the range from 0.05% to 0.5% by weight, calculated to the total weight of the composition B.
- composition B does not contain an alkylparabene such as propyl parabene and/or butyl parabene.
- the composition B comprises at least one polymeric rheology modifier.
- polymeric rheology modifier is understood as a polymer which increases the viscosity of the composition B if added to it.
- the polymeric rheology modifier selected from the group carbomer, xanthan gum and hydroxyethylcellulose. Most preferred are carbomer and/or xanthan gum.
- the total quantity of the polymeric rheology modifier is preferably in the range from 0.01 to 0.8% by weight, more preferably 0.05 to 0.5% by weight and most preferably 0.15 to 0.4% by weight, calculated to the total weight of the composition B.
- compositions B are characterized in that they contain ethanol.
- ethanol is contained in the emulsions according to the invention, it if further preferred if the total quantity of ethanol is in the range from 2% by weight to 6% by weight, calculated to the total weight of the composition B.
- the composition B comprises glycerol, whereby it is further preferred if the total quantity of glycerol is at least 2% by weight, more preferably at least 2.5% by weight, more preferably at least 3% by weight, more preferably at least 5% by weight, more preferably at least 6% by weight, more preferably at least 7% by weight, more preferably at least 8% by weight, more preferably at least 9% by weight, more preferably at least 10% by weight, more preferably at least 11% by weight, more preferably at least 12% by weight; and whereby the total quantity of glycerol should not exceed 14% by weight, calculated to the total weight of the composition B.
- composition B comprises at least cetyl alcohol, stearyl alcohol and/or cetearyl alcohol.
- cetyl alcohol, stearyl alcohol and/or cetearyl alcohol are contained, the total quantity of those substance is preferably in the range from 0.5 to 8% by weight, more preferably from 1 to 6% by weight, calculated to the total weight of the composition B.
- the total quantity of water in composition B is in the range from 45% to 95% by weight, more preferably from 48% to 70% by weight and most preferably from 52% to 65% by weight, calculated to the total weight of the composition B.
- composition B may preferably contain at least one compound selected from the group of limonene, linalool, citral, alpha-isomethylionone and geraniol.
- composition B contains as further ingredients one or more compounds selected from the group of the compounds alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, carnitine, carnosine, natural and I or synthetic isoflavonoids, flavonoids, creatine, creatinine, taurine, p-alanine, tocopheryl acetate, dihydroxyacetone, glycyrrhetinic acid, 8-hexadecene-1 , 16-dicarboxylic acid, glycerylglycose, (2-hydroxyethyl) urea and I or licochalcone A.
- the composition B contains as further ingredients one or more compounds selected from the group of the compounds alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, carnitine, carnosine, natural and I or synthetic isoflavon
- composition B has a pH value in the range from 4.5 to 8.
- the polymer of the invention was synthesized in the following manner:
- Glycerol propoxylate triglycidyl ether (GPTE) (formula II, wherein R 1 is an hydrogen, R 2 is a methyl group and u, v and w are each equal to 1 , was added to 50 ml ethanol and then stirred for 30 min.
- 1 g of Octadecylamine (ODA) was added to the as-prepared solution. The solution was then further stirred for 15 min at 50 °C.
- the obtained polymer had an average molecular weight of 5220 Da, determined using GPC analysis with Polystyrene as calibration standard.
- the resulting molecule was further analyzed and the structure was confirmed, as also described in the article “Amphibious superamphiphilic fabrics with self-healing underwater superoleophilicity’ , (Mater. Horiz., 2019, 6, 122).
- a nucleophilic substitution occurs, wherein amine group of the alkylamine attacks the electrophilic C of the C-0 bond of the epoxide group causing it to break, resulting in ring opening.
- This reaction may occur multiple times resulting in a continuous polymerization network.
- composition A was used in the experiments:
- the experiments determining the absorbance of the protective method were carried out in the following manner:
- the composition A was applied by drip method over a PMMA (Polymethylmethacrylat) plate, all the excess removed and then let it dry between 5 to 30 minutes. Once dried 2 mg/cm 2 of the selected composition B was applied.
- PMMA plates where used normal UV abs. analysis have been done.
- the absorption corresponds directly to the obtained light protection in the UV-A and IIV-B range. The higher the absorption, the higher the protection of the deposited compositions.
- Glycerol propoxylate triglycidyl ether (GPTE) according to formula I, wherein R 1 is a hydrogen atom and x,y and z are each equal to 1 , were added to 50 ml ethanol and then stirred for 30 min.
- ODA Octadecylamine
- reaction products obtained in both reactions were one time further reacted in order to open the remaining epoxide groups.
- pH of the reaction mixture was modified step-wise by addition of 1M HCI to reach pH 2. Via 1 H-NMR in CDCI3 at 300 MHz the change in contained number of epoxide groups was monitored. Before adding HCI the ratio of epoxide group (2.7 ppm) and the partial alkane group (4.1 -3.2 ppm) was 1 :44. After addition to reach pH 2 the ratio was 1 : 188.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
The present invention belongs to the cosmetic field.
Description
Two component sunscreen
The present invention belongs to the cosmetic field and relates to a two component sunscreen composition allowing for an effective protection of the human skin from UV radiation. Furthermore, the invention is directed to a method of protecting the human skin from UV radiation.
A beautiful and attractive appearance is a desire for many people. One typical sign of such an appearance is a healthy and smooth looking skin. Therefore, in order to take care on the skin, it is for many people a daily routine to apply cosmetic products such as body lotions and sunscreen compositions.
For example, compositions containing UV-filters are commonly used to protect the skin from the ultraviolet (UV) radiation of the sunlight. In addition to the acute damage (sunburn), longterm damage such as an increased risk of skin cancer occurs in case of excessive irradiation with light from the UV-B range (wavelength: 280-320 nm). The excessive exposure of UV-B and UV-A radiation (wavelength: 320-400 nm) also leads to a weakening of the elastic and collagen fibers of the connective tissue. This leads to numerous photo-toxic and photo- allergic reactions and results in premature skin ageing.
To protect the skin, a number of light protection filter substances have been developed, which can be used in cosmetic preparations. These UV-A and UV-B filters are grouped in the most developed countries in the form of positive lists such as Annex VI of the Regulation (EC) No 1223/2009 of the European Parliament and of the Council.
However, it is noted that the UV protection of current sunscreen compositions is limited such there is a general need for measures to increase the protection of current sunscreens.
Furthermore, it is often observed that the application of conventional sunscreens comprising UV filters as well as an oil and water phase to the skin may lead to a non-perfect coverage of the skin which then is not fully protected to the UV rays. The reason for the non-perfect coverage of the sunscreen on the skin may be the competitive spreading behavior between the oil and water and the hydrophobic character of the skin. Thus, it remains desirable to
improve the full-coverage of the skin with the UV filters contained in the water and/or oil phase.
Another aspect is that it is often observed that after application of the sunscreen to the human skin the sunscreen may be removed with water e.g. by swimming in the sea. Depending on the sunscreen and UV filter the water resistance of the applied sunscreen may vary. However, the water resistance of conventional sunscreen compositions is still limited. Accordingly, there is a general need to provide measures to increase the water resistance on the human skin of sunscreens.
The documents WO 2013041515 A1 , US 20160166485 A1 and EP 0818450 A1 disclose UV filters and the use thereof.
The article “Amphibious superamphiphilic fabrics with self-healing underwater superoleophilicity’, (Mater. Horiz., 2019, 6, 122) discloses compositions comprising a coating solution prepared by mixing glyceryl propoxylate triglycidyl ether with octadecylamine in ethanol. However, the article does not disclose cosmetic compositions at all.
It was now surprisingly found by the applicant that the disadvantages discussed above can be addressed by the present invention.
The present invention is a method of protection of the human skin from UV radiation, in particular IIV-A and/or IIV-B radiation, involving the steps of a) applying a first cosmetic composition A comprising a polymer polymerized from a monomer mixture comprising
R1 stands independently for an alkylgroup having 1 to 4 carbon atoms or a hydrogen atom,
R2 stands independently for a linear or branched, saturated or non-saturated hydrocarbon group containing 1 to 18 carbon atoms or a hydrogen atom, and u, v, w, x, y and z stand independently for an integer number in the range from 1 to 100; and
(ii) at least one alkylamine comprising 3 to 30 carbon atoms; and b) applying a second cosmetic composition B comprising at least one UV-filter.
A second aspect of the invention is the use of a polymer polymerized from a monomer mixture comprising
(i) at least one triglycidylether according to one of the formulas I to II, wherein R1, R2, u, v, w, x, y and z are defined as described above, and
(ii) at least one alkylamine comprising 3 to 30 carbon atoms; to form a coating on the human skin, which allows the UV protection factor or the UV light protection to be increased if UV-filters are applied onto the coating.
In terms of the present invention the term “UV protection factor or the UV light protection to be increased” is understood in a way that fewer UV-A and UV-B radiation reaches the human skin.
A third aspect of the invention is a cosmetic composition A comprising at least one polymer polymerized from a monomer mixture comprising
(i) at least one triglycidylether according to one of the formulas I to II, wherein R1, R2, u, v, w, x, y and z are defined as described above, and
(ii) at least one alkylamine comprising 3 to 30 carbon atoms.
A forth aspect of the invention is a kit comprising the cosmetic composition A and a second cosmetic composition B, wherein the second composition comprises at least one UV filter.
A fifth aspect of the invention is a polymer polymerized from a monomer mixture comprising
(i) at least one triglycidylether according to one of the formulas I to II, wherein R1, R2, u, v, w, x, y and z are defined as described above, and
(ii) at least one alkylamine comprising 3 to 30 carbon atoms.
It was surprisingly noticed that the invention allows the UV protection factor to be achieved to be significantly increased. Further, a more even coverage of the UV filters is achieved upon application to a skin or a surface. Accordingly, the objectives of the present invention are solved.
All the weight percentages (% by weight) given below relate, unless otherwise stated, to the total weight of the cosmetic composition A.
If ratios of certain components are disclosed in the following description, these ratios refer, unless otherwise stated, to weight ratios of the components.
Unless otherwise stated, all tests and measurements were performed under “normal conditions”. The term "normal conditions" refers to 20°C, 1013 hPa and a relative humidity of 50%.
In the following description the terms ..according to the invention”, “preferred according to the invention” and so on are always directed to the use according to the invention, to the method according to the invention and to the cosmetic composition according to the invention.
For the purposes of the present disclosure, the term "free from" means that the proportion of the respective polymer is less than 0.05% by weight. This ensures that entrainments or impurities with these polymers are not included as "free from" according to the invention.
The term “skin” refers solely to the human skin.
Emulsifiers are understood to be all substances which are listed in the International Cosmetic Ingredient Dictionary and Handbook, Thirteenth Edition 2010, (ISBN 1-882621-47-6) under the name "emulsifying agent". Surfactants are understood to be all substances which are listed in the International Cosmetic Ingredient Dictionary and Handbook, Thirteenth Edition 2010, (ISBN 1-882621-47-6) under the name "surfactant".
Without being bound by the theory it is believed that the amine reacts with the epoxide groups of the triglycidylether allowing a structured network to be created. Alternatively, the amine allows for nucleophilic substitution at the carbon atom with the OH group or the Nu group. It should be noted that every amine may react with up to two triglycidylether such that extensive crosslinking occurs, allowing not a clear chemical structure to be defined.
It is preferred according to the invention if the polymer is polymerized from a monomer mixture comprising
(i) 10% to 90% by weight of at least one triglycidylether according to one of the formulas I to II, wherein R1, R2, u, v, w, x, y and z are defined as described above, and
(ii) 10% to 90% by weight of at least one alkylamine comprising 3 to 30 carbon atoms.
It is further preferred according to the invention if the polymer is polymerized from a monomer mixture comprising
(i) 50% to 90% by weight of at least one triglycidylether according to one of the formulas I to II, wherein R1, R2, u, v, w, x, y and z are defined as described above, and
(ii) 10% to 50% by weight of at least one alkylamine comprising 3 to 30 carbon atoms.
It is more preferred according to the invention if the polymer is polymerized from a monomer mixture comprising
(i) 50% to 90% by weight of at least one triglycidylether according to one of the formulas I to II, wherein R1, R2, u, v, w, x, y and z are defined as described above, and
(ii) 10% to 50% by weight of at least one alkylamine comprising 3 to 30 carbon atoms.
It is most preferred according to the invention if the polymer is polymerized from a monomer mixture comprising
(i) 75% to 88% by weight of at least one triglycidylether according to one of the formulas I to II, wherein R1, R2, u, v, w, x, y and z are defined as described above, and
(ii) 12% to 25% by weight of at least one alkylamine comprising 3 to 30 carbon atoms.
For the case that the polymer is polymerized from a monomer mixture comprising at least one triglycidylether according to formula I, it is preferred if R1 is a hydrogen atom. It is further preferred if the sum of the integer values of x, y and z is less than 20, more preferred less than 10 and most preferred less than 6. It is most preferred if x, y and z are all equal to 1.
For the case that the polymer is polymerized from a monomer mixture comprising at least one triglycidylether according to formula II, it is preferred if R1 is a hydrogen atom. It is further preferred if R2 stands for a methyl group and/or a hydrogen atom, whereby it is most preferred if R2 stands for a methyl group. It is further preferred if the sum of the integer values of u, v and w is less than 20, more preferred less than 10 and most preferred less than 6. It is most preferred if u, v and w are all equal to 1 .
Furthermore, it is preferred if the amine is a primary amine. It is further preferred if the amine comprises a linear alkyl chain comprising 10 to 25 carbon atoms, more preferably 14 to 22 and most preferred 18 carbon atoms.
The polymer of the invention is preferably formed by a) dissolving the triglycidylether accoding to the invention in ethanol, b) then adding the amine to the solution, and c) stirring the obtained mixture to obtain the product.
It is preferred if the ratio by weight between the triglycidylether accoding to the invention and ethanol is in the range from 1:1 to 1 :100, more preferably from 1 :2 to 1:50, more preferably from 1 :5 to 1 :20, and most preferred from 1 :9 to 1 :11.
It is further preferred if the mixture is stirred at 50°C for at least 5 minutes. Most preferably for 12 to 20 minutes.
If desired, ethanol may be removed from the reaction product.
In one further aspect of the present invention it is further preferred if the reaction product obtained in step c) is further reacted in a further step d) with another nucleophile in order to ensure that all epoxide groups are opened and no closed epoxide rings remain in the polymeric structure. Preferred nucleophiles may be selected from the group of water, alcohols, amines, hydrohalic acids, thiols and/or phosphorous acids. Most preferred nucleophils are water, hydrochloric acid, and alcohols.
It is particular preferred if the polymers formed according to the invention are characterized in that they have an average molecular weight in the range from 1000 to 1000000 Dalton, more preferably in the range from 3000 to 100000 Dalton and most preferably 4000 to 10000 Dalton.
According to the invention the average molecular weight of the polymers according to the invention is determined by GPC analysis using a reference material, eg. Poly(styrene) standards.
It is further preferred, if the cosmetic composition A, which is according to the invention, comprises the polymer according to the invention in a total quantity ranging from 0.5 to 30% by weight, more preferably 1 to 20% by weight and most preferably from 5 to 18% by weight, calculated to the total weight of the composition A.
Composition A is further preferably characterized in that in comprises ethanol. If ethanol is contained, the total quantity of ethanol is preferably in the range from 15 to 95% by weight, more preferably from 50 to 90% by weight and most preferably from 60 to 80% by weight, calculated to the total weight of the composition A.
Moreover, it is further preferred if the composition A comprises water. If water is contained, the total quantity of water is preferably in the range from 5 to 95% by weight, more preferably from 15 to 80% by weight and most preferably from 20 to 70% by weight, calculated to the total weight of the composition A.
Additionally, it is further preferred if the composition A comprises glycerol. If glycerol is contained, the total quantity of glycerol is preferably in the range from 1 to 30% by weight, more preferably from 2 to 20% by weight and most preferably from 2 to 10% by weight, calculated to the total weight of the composition A.
The composition A may further comprise additional ingredients commonly contained in cosmetic compositions.
For example, it is preferred if composition A comprises ethylhexylglycerin, hexandiol, and/or phenoxyethanol.
For the case that ethylhexylglycerin is contained it is preferred if the total quantity of ethylhexylglycerin is in the range from 0.1 to 3% by weight, calculated to the total weight of composition A.
For the case that hexandiol is contained it is preferred if the total quantity of hexandiol is in the range from 0.1 to 3% by weight, calculated to the total weight of composition A.
For the case that phenoxyethanol is contained it is preferred if the total quantity of phenoxyethanol is in the range from 0.1 to 3% by weight, calculated to the total weight of composition A.
Furthermore, it is preferred, if composition A comprises propylene glycol, whereby it is further preferred if the total quantity of propylene glycol is in the range from 1 to 30% by weight, calculated to the total weight of the composition A.
Furthermore, the composition A may comprise panthenol, urea, cera microcristallina, cetyl palmitate, sodium hyaluronate, glycyrrhetinic acid, ascorbic acid, caffeine, menthol, titanium oxide, zinc oxide, iron oxide, talc, perfume and/or emulsifier.
In one aspect of the present invention the composition A is characterized in that no UV-filter is contained.
In another aspect of the present invention the composition A comprises at least one water- soluble UV filter. Embodiments of the present invention which are advantageous according to the invention are characterized in that the total amount of water-soluble UV filters in the preparation is from 0.1 to 18% by weight, based on the total weight of the composition A.
It is advantageous according to the invention if sulfonic acid salts are used as water-soluble UV filters. Preferred examples are 1 , 4-di (2-oxo-10-sulfo-3-bomylidenemethyl) benzene and its salts; 4- (2-oxo-3-bornylidenemethyl) benzenesulfonic acid; 2-methyl-5- (2-oxo-3- bornylidenemethyl) sulfonic acid salts; Terephthalidendicamphersulfonsaure; Compounds 2- phenylbenzimidazole-5-sulfonic acid and I or salts thereof and I or phenylene-1,4-bis (2- benzimidazyl) -3,3'-5,5'-tetrasulfonic acid salts.
The counterion of the salts is usually sodium, potassium or ammonium ions, the sodium salts being preferred according to the invention.
According to the invention, the water-soluble UV filters are preferably selected from the group of the compounds 2-phenylbenzimidazole-5-sulfonic acid and I or salts thereof and I or phenylene-1 ,4-bis (2-benzimidazyl) -3,3'-5 , 5'-tetrasulfonsauresalze. The use of 2- phenylbenzimidazole-5-sulfonic acid and I or salts thereof is particularly preferred according to the invention.
The preferred use concentration for 2-phenylbenzimidazole-5-sulfonic acid and I or salts thereof is from 0.1 to 12% by weight, based on the total weight of the composition A.
Furthermore, it is still possible and preferred if composition A comprises at least one additional UV-filter, which may preferably be selected from the group consisting of 2,2'- methylene-bis- (6- (2H-benzotriazol-2-yl) -4- (1 , 1 , 3,3-tetramethylbutyl) phenol); 2- (2H- Benzotriazol-2-yl) -4-methyl-6- [2-methyl-3- [1 ,3,3,3-tetramethyl-1 - [(trimethylsilyl) oxy] disiloxanyl] propyl] phenol ; 3- (4-methylbenzylidene) camphor; 3-benzylidenecamphor; ethylhexyl salicylate; 2-ethylhexyl-2-cyano-3,3-diphenylacrylate; 4- (dimethylamino) benzoic
acid (2-ethylhexyl) ester; 4- (dimethylamino) benzoic acid amyl ester; 4- Methoxybenzalmalon-sauredi (2-ethylhexyl) ester; 4-methoxycinnamate (2-ethylhexyl) ester; Isoamyl 4-methoxycinnamate; 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'- methylbenzophenone; 2,2'-dihydroxy-4-methoxybenzophenone; homomenthyl; 2-ethylhexyl 2-hydroxybenzoate; dimethicodiethylbenzalmalonate; 3- (4- (2,2-ethoxycarbonylvinyl) phenoxy) propenyl) methoxysiloxane I dimethylsiloxane copolymer; 4- (tert-butyl) -4'- methoxydibenzoylmethane; Hexyl 2- (4'-diethylamino-2'-hydroxybenzoyl) benzoate; dioctylbutylamidotriazone (INCI: diethylhexyl-butamidotriazone); 2,4-bis- [5-1 (dimethylpropyl) benzoxazol-2-yl- (4-phenyl) imino] -6- (2-ethylhexyl) -imino-1,3,5-triazine having the (CAS No 288254-16-0); 2,4-Bis - {[4- (2-ethylhexyl oxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1, 3,5-triazine (INCI: bis-ethylhexyloxyphenol methoxyphenyl triazine) ; 4,4 4 "- (1,3,5-triazine- 2 ,4,6-triyltriimino) tris-benzoic acid tris (2-ethylhexyl ester) (also: 2 ,4,6-tris [anilino] (p-carbo- 2'-ethyl-1'-hexyloxy)] - 1 , 3,5-triazine (INCI: ethylhexyl triazone); 2, 4, 6-tribiphenyl-4-yl-1, 3,5- triazine merocyanines; titanium dioxide and zinc oxide.
Although, for the case that the composition A contains at least one UV filter, it is already possible to enhanced the UV protection by applying composition A, it was surprisingly noticed that the optimum UV protection may be achieved if composition A is applied to the human skin in a first step and in a second step a conventional cosmetic sunscreen, herein named as composition B, is applied.
It is an advantage, if the composition B is an emulsion. Emulsions, here in particular W/O, O/W or W/O/W emulsions, are often used as cosmetic or medical preparations. Emulsions are generally understood as meaning heterogeneous systems which comprise two liquids which are immiscible or only miscible with one another to a limited extent, which liquids are normally referred to as phases. In an emulsion, one of the two liquids is dispersed in the other liquid in the form of very fine droplets.
If the two liquids are water and oil and if oil droplets are finely distributed in water, then this is an oil in water emulsion (O/W emulsion, e.g., milk). The basic character of an O/W emulsion is determined by the water. In the case of a water-in-oil emulsion (W/O emulsion, e.g., butter), the principle is reversed, the basic character here being determined by the oil.
Alternatively, composition B is a single phase alcohol (ethanol) containing formulation. High quantities of ethanol are used in this kind of formulations in order to provide a clear solution
of all ingredients. The amount is ethanol is chosen to be sufficient to form a stable and transparent single phase formulation.
In accordance with the present invention the composition B is preferably characterized in that it is an O/W emulsion, a W/O emulsion or a single phase alcoholic solution.
Composition B comprises at least one UV filter.
Composition B according to the invention is advantageously characterized in that the composition comprises one or more organic IIV-A filters selected from the group of the compounds 4- (tert-butyl) -4'-methoxydibenzoylmethane and 2- (4'-diethylamino-2 ' - hydroxybenzoyl) -benzoic acid hexyl ester.
It is inventively preferred if the organic IIV-A filter compound 4- (tert-butyl) -4'- methoxydibenzoylmethane is used in composition B.
The advantageous total use according to the invention for the organic IIV-A filter, in particular 4- (tert-butyl) -4'-methoxydibenzoylmethane and/or 2- (4'-diethylamino-2'- hydroxybenzoyl) - benzoic acid hexyl ester, is/are from 1 to 5 weight -%, preferably 1.5 to 4.5% by weight, particularly preferably 2 to 4% by weight, based on the total weight of the composition B.
Embodiments of the present invention which are advantageous according to the invention are characterized in that the composition B contains one or more organic UV filters selected from the group of the compounds 2-phenylbenzimidazole-5-sulphonic acid and/or salts thereof; phenylene-1,4-bis(2-benzimidazyl)-3,3'-5,5'-tetrasulphonic acid salts; 1,4-di(2-oxo- 10-sulpho-3-bornylidenemethyl)benzene and salts thereof; 4-(2-oxo-3- bornylidenemethyl)benzenesulphonic acid salts; 2-methyl-5-(2-oxo-3- bornylidenemethyl)sulphonic acid salts; 2,2'-methylenebis(6-(2H-benzotriazol-2-yl)-4- (1,1 , 3, 3-tetramethyl butyl) phenol); 2-(2H-benzotriazol-2-yl)-4-methyl-6-[2-methyl-3-[1 ,3,3,3- tetramethyl-1-[(trimethylsilyl)oxy]disiloxanyl]propyl]phenol; 3-(4-methylbenzylidene)camphor; 3-benzylidenecamphor; terephthalidenedicamphorsulphonic acid; 2-ethylhexyl 2-cyano-3,3- diphenylacrylate; 2-ethylhexyl 4-(dimethylamino)benzoate; amyl 4-(dimethylamino)benzoate; di(2-ethylhexyl) 4-methoxybenzalmalonate; 2-ethylhexyl 4-methoxycinnamate; isoamyl 4- methoxycinnamate; 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'- methylbenzophenone; 2,2'-dihydroxy-4-methoxybenzophenone; homomenthyl salicylate; 2-
ethylhexyl 2- hydroxy benzoate; dimethicodiethylbenzalmalonate; 3-(4-(2,2- bisethoxycarbonylvinyl)phenoxy)propenyl)methoxysiloxane/dimethylsiloxan e copolymer; dioctylbutylamidotriazone (INCI: Diethylhexyl Butamido Triazone); 2,4-bis[5-1 (dimethylpropyl)benzoxazol-2-yl(4-phenyl)imino]-6-(2-ethylhexyl)imino-1,3,5-triazine with (CAS No. 288254-16-0); tris(2-ethylhexyl) 4,4',4"-(1,3,5-triazine-2,4,6- triyltriimino)trisbenzoate (also: 2,4,6-tris[anilino(p-carbo-2'-ethyl-1'-hexyloxy)]-1 ,3,5-triazine (INCI: Ethylhexyl Triazone); 2,4,6-tribiphenyl-4-yl-1 ,3,5-triazine; and merocyanine.
It is inventively preferred if the composition B contains 2-phenylbenzimidazole-5-sulfonic acid and I or salts thereof. For the case that the composition B contains 2-phenylbenzimidazole-5- sulfonic acid and I or salts the total quantity of those substances is preferably in the range from 0.5 to 5% by weight, more preferably 0.6 to 4.5% by weight and most preferably 0.8 to 4% by weight, based on the total weight of the composition B.
It is further advantageous if the composition B comprises 2-ethylhexyl-2-cyano-3,3- diphenylacrylate (octocrylene), whereby it is further preferred if the total quantity of this substance is in the range from 1 to 12% by weight, preferably 1.5 to 6% by weight, particularly preferably 2 to 3.5% by weight based on the total weight of composition B.
It is further preferred if the composition B comprises Homosalate in a total quantity from 1 to 12% by weight, preferably 1.5 to 6% by weight, particularly preferably 2 to 3.5% by weight based on the total weight of composition B.
It is further preferred if the composition B comprises Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine in a total quantity from 0.5 to 12% by weight, preferably 0.6 to 6% by weight, particularly preferably 0.7 to 2.5% by weight based on the total weight of composition B.
It is further preferred if the composition B comprises Ethylhexyl Salicylate in a total quantity from 0.5 to 12% by weight, preferably 2 to 9% by weight, particularly preferably 3 to 7.5% by weight based on the total weight of composition B.
It is further preferred if the composition B comprises Silica Dimethyl Silylate in a total quantity from 0.1 to 2% by weight, preferably 0.4 to 1.5% by weight, particularly preferably 0.6 to 1.3% by weight based on the total weight of composition B.
Moreover, the composition B of the present invention is preferably characterized in that at least one inorganic UV-filter is contained, especially zinc oxide and/or titanium dioxide. It is
especially preferred, if the total quantity of zinc oxide and/or titanium dioxide in the composition B of the present invention is in the range from 0.1 to 5% by weight, calculated to the total weight of the composition B.
For the case that composition B is an emulsion, it is preferred if the total quantity of the oil phase in the composition B is in the range from 0.9 to 25% by weight, more preferably 1 to 20% by weight, more preferably 1.1 to 19% by weight and most preferably from 1.2 to 18% by weight, calculated to the total weight of the composition B.
For the case that composition B is an emulsion, it is preferred if the ratio of the total quantity of the emulsifier to the total quantity of the oil phase is in the range from 1:1 to 1 :7, more preferably 1:1.1 to 1 :4, more preferably 1 :1.2 to 1:3 and most preferably 1:1.4 to 1:2.8. It is noted that by definition emulsifier and surfactants are not calculated to the total quantity of the oil phase.
According to the invention, it is further preferred if the composition B contains phenoxyethanol. In the case the composition B contains phenoxyethanol the total quantity of phenoxyethanol is preferably in the range from 0.1 % by weight to 2% by weight and more preferably from 0.4% by weight to 1% by weight, calculated to the total weight of the composition B.
Moreover, preferred composition B of the present invention are therein characterized that they contain ethylhexylglycerin, whereby it is further preferred if the total quantity of ethylhexylglycerin is in the range from 0.05% to 0.5% by weight, calculated to the total weight of the composition B.
Furthermore, it is preferred if the composition B does not contain an alkylparabene such as propyl parabene and/or butyl parabene.
According to the invention it is further preferred if the composition B comprises at least one polymeric rheology modifier. The term “polymeric rheology modifier” is understood as a polymer which increases the viscosity of the composition B if added to it. Preferred are the polymeric rheology modifier selected from the group carbomer, xanthan gum and hydroxyethylcellulose. Most preferred are carbomer and/or xanthan gum.
The total quantity of the polymeric rheology modifier is preferably in the range from 0.01 to 0.8% by weight, more preferably 0.05 to 0.5% by weight and most preferably 0.15 to 0.4% by weight, calculated to the total weight of the composition B.
In addition, preferred compositions B are characterized in that they contain ethanol. In the case that ethanol is contained in the emulsions according to the invention, it if further preferred if the total quantity of ethanol is in the range from 2% by weight to 6% by weight, calculated to the total weight of the composition B.
Further, it is preferred if the composition B comprises glycerol, whereby it is further preferred if the total quantity of glycerol is at least 2% by weight, more preferably at least 2.5% by weight, more preferably at least 3% by weight, more preferably at least 5% by weight, more preferably at least 6% by weight, more preferably at least 7% by weight, more preferably at least 8% by weight, more preferably at least 9% by weight, more preferably at least 10% by weight, more preferably at least 11% by weight, more preferably at least 12% by weight; and whereby the total quantity of glycerol should not exceed 14% by weight, calculated to the total weight of the composition B.
Preferred embodiments of the invention are further characterized in that the composition B comprises at least cetyl alcohol, stearyl alcohol and/or cetearyl alcohol. In the case cetyl alcohol, stearyl alcohol and/or cetearyl alcohol are contained, the total quantity of those substance is preferably in the range from 0.5 to 8% by weight, more preferably from 1 to 6% by weight, calculated to the total weight of the composition B.
Additionally, it is preferred according to the invention if the total quantity of water in composition B is in the range from 45% to 95% by weight, more preferably from 48% to 70% by weight and most preferably from 52% to 65% by weight, calculated to the total weight of the composition B.
According to the invention the composition B may preferably contain at least one compound selected from the group of limonene, linalool, citral, alpha-isomethylionone and geraniol.
Embodiments of the present invention which are advantageous according to the invention are characterized in that the composition B contains as further ingredients one or more compounds selected from the group of the compounds alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, carnitine, carnosine, natural and I or synthetic isoflavonoids, flavonoids, creatine, creatinine, taurine, p-alanine, tocopheryl acetate,
dihydroxyacetone, glycyrrhetinic acid, 8-hexadecene-1 , 16-dicarboxylic acid, glycerylglycose, (2-hydroxyethyl) urea and I or licochalcone A.
According to the invention it is further preferred if the composition B has a pH value in the range from 4.5 to 8.
Examples:
The following examples should illustrate the compositions of this invention, without intending to limit the invention to these examples. The numerical values in the examples are percentages by weight, based on the total weight of the compositions.
The polymer of the invention was synthesized in the following manner:
5 g of Glycerol propoxylate triglycidyl ether (GPTE) (formula II, wherein R1 is an hydrogen, R2 is a methyl group and u, v and w are each equal to 1 , was added to 50 ml ethanol and then stirred for 30 min. 1 g of Octadecylamine (ODA) was added to the as-prepared solution. The solution was then further stirred for 15 min at 50 °C.
The obtained polymer had an average molecular weight of 5220 Da, determined using GPC analysis with Polystyrene as calibration standard. The resulting molecule was further analyzed and the structure was confirmed, as also described in the article “Amphibious superamphiphilic fabrics with self-healing underwater superoleophilicity’ , (Mater. Horiz., 2019, 6, 122).
In the reaction process a nucleophilic substitution occurs, wherein amine group of the alkylamine attacks the electrophilic C of the C-0 bond of the epoxide group causing it to break, resulting in ring opening. This reaction may occur multiple times resulting in a continuous polymerization network.
For the following experiments, the output of the procedure described above was used under the designation polymer blend.
The experiments determining the absorbance of the protective method were carried out in the following manner:
The composition A was applied by drip method over a PMMA (Polymethylmethacrylat) plate, all the excess removed and then let it dry between 5 to 30 minutes. Once dried 2 mg/cm2 of the selected composition B was applied. When PMMA plates where used normal UV abs. analysis have been done. The absorption corresponds directly to the obtained light protection in the UV-A and IIV-B range. The higher the absorption, the higher the protection of the deposited compositions.
Further synthesis were performed:
5 g of Glycerol propoxylate triglycidyl ether (GPTE) according to formula I, wherein R1 is a hydrogen atom and x,y and z are each equal to 1 , were added to 50 ml ethanol and then stirred for 30 min. 1 g of Octadecylamine (ODA) was added to the as-prepared solution. The solution was then further stirred for 15 min at 50 °C to obtain the final product.
The reaction products obtained in both reactions were one time further reacted in order to open the remaining epoxide groups. In order to do that Water was added to the reaction solution then pH of the reaction mixture was modified step-wise by addition of 1M HCI to reach pH 2. Via 1H-NMR in CDCI3 at 300 MHz the change in contained number of epoxide
groups was monitored. Before adding HCI the ratio of epoxide group (2.7 ppm) and the partial alkane group (4.1 -3.2 ppm) was 1 :44. After addition to reach pH 2 the ratio was 1 : 188.
All blends obtained were individually mixed with ethanol in a ratio of 12:88. Further all obtained mixtures were individually used in combination with the compositions B as disclosed above.
Furthermore, all blends of the prepared polymers and ethanol, were mixed with 2- phenylbenzimidazole-5-sulfonic acid, whereby the total quantity of 2-phenylbenzimidazole-5- sulfonic acid was 5% by weight, calculated to the total weight of all contained ingredients.
Claims
1 . Method of protection of the human skin from UV radiation, in particular IIV-A and/or UV-B radiation, involving the steps of a) applying a first cosmetic composition A comprising a polymer polymerized from a monomer mixture comprising
R1 stands independently for an alkylgroup having 1 to 4 carbon atoms or a hydrogen atom,
R2 stands independently for a linear or branched, saturated or nonsaturated hydrocarbon group containing 1 to 18 carbon atoms or a hydrogen atom, and u, v, w, x, y and z stand independently for an integer number in the range from 1 to 100; and
(ii) at least one alkylamine comprising 3 to 30 carbon atoms; and b) applying a second cosmetic composition B comprising at least one UV-filter.
Method according to claim 1 characterized in that the polymer is polymerized from a monomer mixture comprising
(i) 10% to 90% by weight of at least one trig lycidy lether according to one of the formulas I to II, wherein R1, R2, u, v, w, x, y and z are defined as described in claim 1, and
(ii) 10% to 90% by weight of at least one alkylamine comprising 3 to 30 carbon atoms. Method according to any of the proceeding claims characterized in that the polymer is polymerized from a monomer mixture comprising
(i) 50% to 90% by weight of at least one triglycidylether according to one of the formulas I to II, wherein R1, R2, u, v, w, x, y and z are defined as described in claim 1, and
(ii) 10% to 50% by weight of at least one alkylamine comprising 3 to 30 carbon atoms. Method according to any of the proceeding claims characterized in that the polymer is polymerized from a monomer mixture comprising
(i) 75% to 88% by weight of at least one triglycidylether according to one of the formulas I to II, wherein R1, R2, u, v, w, x, y and z are defined as described in claim 1, and
(ii) 12% to 25% by weight of at least one alkylamine comprising 3 to 30 carbon atoms. Method according to any of the proceeding claims characterized in that the polymer is polymerized from a monomer mixture comprising at least one triglycidylether according to formula I, whereby R1 is a hydrogen atom and the integer values of x, y and z is less than 20, more preferred less than 10, still more preferred less than 6 and most preferred x, y and z are all equal to 1. Method according to any of the proceeding claims characterized in that the polymer is polymerized from a monomer mixture comprising at least one triglycidylether according to formula II, whereby R1 is a hydrogen atom, R2 stands for a methyl group and/or a hydrogen atom, and the integer values of u, v and w is less than 20, more preferred less than 10, still more preferred less than 6 and most preferred u, v and w are all equal to 1.
Method according to any of the proceeding claims characterized in that the amine is a primary amine. Method according to any of the proceeding claims characterized in that the amine comprises a linear alkyl chain comprising 10 to 25 carbon atoms, more preferably 14 to 22 and most preferred 18 carbon atoms. Method according to any of the proceeding claims characterized in that the polymer is preferably formed by a) dissolving the triglycidylether in ethanol, b) then adding the amine to the solution, and c) then stirring the obtained mixture to obtain the product. Method according to claim 9 characterized in that the reaction product obtained in step c) is further reacted in a further step d) with a nucleophile in order to open the remaining epoxide groups. Method according to claim 10 characterized in that the nucleophile is selected from the group of water, alcohols, amines, hydrohalic acids, thiols and/or phosphorous acids. Method according to claim 10 characterized in that the nucleophile is selected from the group of water, hydrochloric acid, and alcohols. Method according to any of the proceeding claims characterized in that the cosmetic composition A comprises the polymer according to the invention in a total quantity ranging from 0.5 to 30% by weight, more preferably 1 to 20% by weight and most preferably from 5 to 18% by weight, calculated to the total weight of the composition A. Method according to any of the proceeding claims characterized in that the cosmetic composition A comprises at least one water-soluble UV filter. Method according to any of the proceeding claims characterized in that the composition B contains one or more organic UV filters selected from the group of the compounds 2-phenylbenzimidazole-5-sulphonic acid and/or salts thereof; phenylene- 1 ,4-bis(2-benzimidazyl)-3,3'-5,5'-tetrasulphonic acid salts; 1,4-di(2-oxo-10-sulpho-3- bornylidenemethyl)benzene and salts thereof; 4-(2-oxo-3-
bornylidenemethyl)benzenesulphonic acid salts; 2-methyl-5-(2-oxo-3- bornylidenemethyl)sulphonic acid salts; 2,2'-methylenebis(6-(2H-benzotriazol-2-yl)-4- (1 ,1 , 3, 3-tetramethyl butyl) phenol); 2-(2H-benzotriazol-2-yl)-4-methyl-6-[2-methyl-3- [1 ,3,3,3-tetramethyl-1-[(trimethylsilyl)oxy]disiloxanyl]propyl]phenol; 3-(4- methylbenzylidene)camphor; 3-benzylidenecamphor; terephthalidenedicamphorsulphonic acid; 2-ethylhexyl 2-cyano-3,3-diphenylacrylate; 2-ethylhexyl 4-(dimethylamino)benzoate; amyl 4-(dimethylamino)benzoate; di(2- ethylhexyl) 4-methoxybenzalmalonate; 2-ethylhexyl 4-methoxycinnamate; isoamyl 4- methoxycinnamate; 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'- methylbenzophenone; 2,2'-dihydroxy-4-methoxybenzophenone; homomenthyl salicylate; 2-ethylhexyl 2-hydroxybenzoate; dimethicodiethylbenzalmalonate; 3-(4- (2,2-bisethoxycarbonylvinyl)phenoxy)propenyl)methoxysiloxane/dimethylsiloxan e copolymer; dioctylbutylamidotriazone; 2,4-bis[5-1 (dimethylpropyl)benzoxazol-2-yl(4- phenyl)imino]-6-(2-ethylhexyl)imino-1 ,3,5-triazine with; tris(2-ethylhexyl) 4,4',4"-(1 ,3,5- triazine-2,4,6-triyltriimino)trisbenzoate (also: 2,4,6-tris[anilino(p-carbo-2'-ethyl-1'- hexyloxy)]-1 ,3,5-triazine; 2,4,6-tribiphenyl-4-yl-1 ,3,5-triazine; and merocyanine. Use of a polymer polymerized from a monomer mixture comprising a) at least one triglycidylether according to one of the formulas I to II,
wherein R1, R2, u, v, w, x, y and z are defined as described in claim 1 , and b) at least one alkylamine comprising 3 to 30 carbon atoms;
to form a coating on the human skin, which allows the UV light protection to be increased if UV-filters are applied onto the coating.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20207953.9A EP4000692A1 (en) | 2020-11-17 | 2020-11-17 | Two component sunscreen |
EP20207953.9 | 2020-11-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022106123A1 true WO2022106123A1 (en) | 2022-05-27 |
Family
ID=73455539
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2021/078091 WO2022106123A1 (en) | 2020-11-17 | 2021-10-12 | Two component sunscreen |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP4000692A1 (en) |
WO (1) | WO2022106123A1 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1154901B (en) * | 1961-02-22 | 1963-09-26 | Wella Ag | Method of making a permanent hairstyle |
EP0818450A1 (en) | 1996-07-08 | 1998-01-14 | Ciba SC Holding AG | Triazine derivatives as UV filter in sunscreen products |
EP2359801A1 (en) * | 2008-12-03 | 2011-08-24 | Shiseido Co., Ltd. | Oil-in-water cosmetic |
WO2013041515A1 (en) | 2011-09-20 | 2013-03-28 | Dsm Ip Assets B.V. | Novel polyester based uv filters |
US20160166485A1 (en) | 2013-07-26 | 2016-06-16 | Sasol Germany Gmbh | Transparent Sunscreen Compositions and Use Thereof |
-
2020
- 2020-11-17 EP EP20207953.9A patent/EP4000692A1/en not_active Withdrawn
-
2021
- 2021-10-12 WO PCT/EP2021/078091 patent/WO2022106123A1/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1154901B (en) * | 1961-02-22 | 1963-09-26 | Wella Ag | Method of making a permanent hairstyle |
EP0818450A1 (en) | 1996-07-08 | 1998-01-14 | Ciba SC Holding AG | Triazine derivatives as UV filter in sunscreen products |
EP2359801A1 (en) * | 2008-12-03 | 2011-08-24 | Shiseido Co., Ltd. | Oil-in-water cosmetic |
WO2013041515A1 (en) | 2011-09-20 | 2013-03-28 | Dsm Ip Assets B.V. | Novel polyester based uv filters |
US20160166485A1 (en) | 2013-07-26 | 2016-06-16 | Sasol Germany Gmbh | Transparent Sunscreen Compositions and Use Thereof |
Non-Patent Citations (4)
Title |
---|
"Amphibious superamphiphilic fabrics with self-healing underwater superoleophilicity", MATER. HORIZ., vol. 6, 2019, pages 122 |
"International Cosmetic Ingredient Dictionary and Handbook", 2010, article "emulsifying agent" |
CAS , no. 288254-16-0 |
FU SIDA ET AL: "Amphibious superamphiphilic fabrics with self-healing underwater superoleophilicity", MATER. HORIZ., vol. 6, no. 1, 9 January 2019 (2019-01-09), pages 122 - 129, XP055800485, ISSN: 2051-6347, DOI: 10.1039/C8MH00898A * |
Also Published As
Publication number | Publication date |
---|---|
EP4000692A1 (en) | 2022-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2751727T3 (en) | Octocrylene-free sunscreen, containing alcohol | |
ES2319445T3 (en) | 2-PHENYLENE BENZOATE IN COPSMETIC EMULSIONS OIL-IN-WATER PROTECTION AGAINST UV LIGHT. | |
EP2280767B1 (en) | Light protection filter combination comprising 2,4,6-tris-(biphenyl)-1,3,5-triazine | |
ES2781977T3 (en) | Sunscreen product containing titanium dioxide with octocrylene | |
EP1962781A1 (en) | Transparent sunscreen agents | |
EP2781211B1 (en) | Stable cosmetic preparation | |
ES2786599T3 (en) | Sunscreen product containing titanium dioxide with ethylhexyl salicylate | |
ES2749685T3 (en) | Octocrylene free sunscreen product containing diethylaminohydroxybenzoylhexyl benzoate | |
BRPI1105655B1 (en) | USES OF ALCANODIO, MIXTURE, COMPOSITION FOR MANUFACTURING COSMETIC PREPARATION, COSMETIC PREPARATION, METHOD FOR INCREASING THE SOLUBILITY OF AN ORGANIC SUBSTANCE AND METHOD FOR MANUFACTURING MIXTURE, COMPOSITION AND PREPARATION | |
WO2007068709A1 (en) | Merocyanine-containing sunscreens having a great degree of uv-a balance | |
EP1965870A2 (en) | Sunscreen agent comprising merocyanines and triazines | |
WO2014012699A2 (en) | Latest cosmetic sunscreen spray | |
DE102016000533A1 (en) | New octocrylene-free sunscreen with diethylaminohydroxybenzylhexylbenzoate | |
ES2698548T5 (en) | Octocrylene free sunscreen product with minimal stickiness | |
EP2839824A2 (en) | Sun protection with high triazine content | |
DE102006013283A1 (en) | Sprayable sunscreen lotion | |
EP1857096B1 (en) | Sprayable sun protection agent | |
WO2022106123A1 (en) | Two component sunscreen | |
US20080193395A1 (en) | Cosmetic preparation with vinylpyrrolidone/acrylic acid copolymer | |
DE202008017353U1 (en) | Cosmetic preparation with neutralized 2-phenylbenzimidazole-5-sulfonic acid | |
DE102013209904A1 (en) | Stable cosmetic preparation | |
ES2846904T3 (en) | Cosmetic foam containing an emulsion UV filter containing sodium cetearyl sulfate and glyceryl monostearate | |
EP4000693A1 (en) | Two component moisturizer | |
US20230083509A1 (en) | Polyacrylate-free cosmetic preparation | |
ES2963316T3 (en) | O/W emulsion with photochemically stable 4-(tert-butyl)-4¿-methoxydibenzoylmethane in oil droplets smaller than 8 micrometers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21783325 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21783325 Country of ref document: EP Kind code of ref document: A1 |